• HOME
  • Universe A-Z
  • PSYCH STOCK NEWS
  • PSYCH NEWS
  • RESEARCH
  • TESTIMONIALS
  • CLINICAL TRIALS
  • CONFERENCES
  • 2024 PSYCHEDELIC INVESTOR CONFERENCE
Search
Psychedelic Stock Review

INTERVIEW

  • 2023 Watch List
  • 2024 WATCH LIST
  • ALCOHOL
  • CHARITY
  • CLIENT
  • CLINICAL TRIALS
  • CLINICS
  • CONFERENCES
  • DECK
  • INTERVIEW
  • INVESTORS
  • IPO
  • LARGE CAP PSYCH
  • NEO
  • PSYCH FUND | ETF
  • PSYCH NEWS
  • PSYCH STOCK NEWS
  • Psychedelic Investor Guide
  • Psychedelic Investor TV
  • RESEARCH
  • SIDE STORIES
  • STUFF
  • SUBSCRIBE
  • TESTIMONIALS
  • UNIVERSE
  • VETS
  • VIDEOS

    Journey Medical’s Growing Army of 1,000 Ketamine Therapists, are Available 24-7....

    Editor | Curator - January 30, 2024

    Psycheceutical’s (BWVI) Topical Ketamine: A Game-Changer for PTSD?

    Editor | Curator - January 4, 2024

    Psycheceutial Biosciences (BWVI) Listed on WeFunder!

    Editor | Curator - November 1, 2023

    Psychedelics CURED My Alcoholism

    October 28, 2023

    ClearMind’s (CMND) MEAI and Reducing Alcohol Use.

    October 27, 2023
    Dr Deborah Nash

    Interview: Dr. Deborah Nash, Ibogaine and Miami Based DemeRX.

    June 4, 2023

    Psychedelic Marketing Tips: Adrian Morrison

    May 24, 2023

    Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes

    May 15, 2023

    Ketamine and Yale University

    May 15, 2023

    PSYCHECEUTICAL TO CONDUCT THE FIRST EVER PHASE I AND II CLINICAL...

    February 22, 2023

    Stan Grof, Psychedelic’s Elder Statesman.

    August 15, 2022

    Small Pharma (DMT, DMTTF) $0.46 a Small and Extremely Interesting Psychedelic...

    November 4, 2021

    Psychedelic Drugs ‘Far Exceed’ Cannabis Investment Potential (CNBC)

    October 19, 2021
    12Page 1 of 2
    ABOUT US
    FOLLOW US
    • About – Contact
    • Institutional Investors
    • Analysts
    • Side Stories
    • Disclaimer
    ©